Abstract:Parkinson's disease (PD) is a common neurodegenerative disorder in aging and loss of dopamine (DA) in nigrostriatal system is an important character of PD. Animal models is very useful in the research of pathogenesis of PD. However, the DA content is not always decreased in the nigrostriatal system of these models as the situation of PD patients. Viral vector-based PD models in animals were newly developed technologies in recent years, and these models showed progressive neurodegenerative in nigrostriatal system and behavioural changes. As the other models, the DA conent of this model is also complex among different researchers. In this study, rAAV was used to transfer gene to the rat brain. Three different viral vectors consist of EGFP, α-synuclein wild type (WT) and α-synuclein A53T mutation was injected to the substantia nigra pars compacta (SNpc) to established the EGFP or α-synuclein over-expression models. After 16 weeks, the protein expression was determined by immunofluorescence and the loss of neurons in nigrostriatal system was detected by immunohistochemistry. The results showed that loss of dopaminergic neurons with positive correlation to the expression of α-synuclein, and the loss is even serious in the α-synuclein A53T group. It is indicated that the PD models were established successfully. HPLC-MS/MS was used to detect the neurotransmitter in the nigrostriatal system of these rat models of PD. The samples were separated by HS-F5 column, then detect in MS/MS using MRM mode which can analysis all of the neurotransmitters consist of DA, serotonin (5-HT) and their metabolites in one injection. The results showed the DA was decreased with its metabolites were increased whereas the 5-HT and its metabolite were increased. The results showed the neurotransmitter metabolism was disorder in rat models of PD. Our study focused on the neurotransmitter metabolism of rat model of PD, and it may provide a useful understanding of these models.

Assessment of Salsolinol N-methyltransferase Activity in the Wistar Rat Brains

Assessment of Salsolinol N -Methyltransferase Activity in Rat Peripheral Lymphocytes by Liquid Chromatography–electrospray Time-of-flight Mass Spectrometry

Determination of salsolinol N-methyltransferase activity in 6-OHDA-lesioned rats

Characterization of salsolinol synthase from rat brain

Activity Assay of Salsolinol Synthase using High Performance Liquid Chromatography-Electrochemical Detection

Existence and Characterization of Salsolinol Synthase in Neuronal Cells and Rat Brain

Changes in salsolinol production and salsolinol synthase activity in Parkinson's disease model.

An Overview of Endogenous Catechol-Isoquinolines and Their Related Enzymes: Possible Biomarkers for Parkinson’s Disease

Enzymatic Condensation of Dopamine and Acetaldehyde: a Salsolinol Synthase from Rat Brain

Formation and Metabolism of Catecholamine Isoquinolines in the 6-OHDA Lesion rat Model Brains

S-adenosyl Methionine Enhance the Toxicity of Salsolinol in Dopaminergic SH-SY5Y Cell

Abnormal DNA Methylation in Substantia Nigra Region of MPTP-induced Mouse Model of Parkinson's Disease

[A study of microPET for assessing regional cerebral glucose metabolism and the expression of dopamine receptor type 2 in a rat model of Parkinson's disease].

Effect Of (R)-Salsolinol And N-Methyl-(R)-Salsolinol On The Balance Impairment Between Dopamine And Acetylcholine In Rat Brain: Involvement In Pathogenesis Of Parkinson Disease

Sal Synthase Induced Cytotoxicity of PC12 Cells Through Production of the Dopamine Metabolites Salsolinol and N-methyl-salsolinol.

A New Microdialysis-Electrochemical Device for in Vivo Simultaneous Determination of Acetylcholine and Choline in Rat Brain Treated with N-methyl-(R)-salsolinol

In Vivo Detection of Metabolic Changes in the Striatum of Proteasomal Inhibition-Induced Parkinson's Disease in Rats Using Proton MR Spectroscopy at 9.4 T.

In Vivo Study on the Monoamine Neurotransmitters and Their Metabolites Change in the Striatum of Parkinsonian Rats by Liquid Chromatography with an Acetylene Black Nanoparticles Modified Electrode

Exploring the Therapeutic Effects of Multifunctional N -Salicylic Acid Tryptamine Derivative against Parkinson’s Disease

Quantitative Detection of Dopamine, Serotonin and Their Metabolites in Rat Model of Parkinson's Disease Using HPLC-MS/MS

Proton Magnetic Resonance Spectroscopic Changes in the Striatum in Rat Model of Parkinson's Disease